Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Radiotherapy-induced metabolic hallmarks in the tumor microenvironment

Trends in cancer(2022)10.1016/j.trecan.2022.05.005Source: DataRank Database

Radiotherapy-induced metabolic hallmarks in the tumor microenvironment is a research paper published in Trends in cancer (2022). On theSindex it has a DataRank of 0. It has been cited 63 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

63 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.95)OA: closedTopics (26)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Minal Nenwani,Itisam Sarangi,Abhinav Achreja ORCID,Theodore S. Lawrence ORCID,Deepak Nagrath ORCID

Live enrichment

PubMed:35750630 OpenAlex:https://openalex.org/W4283273421

National Cancer Institute

Grant: R01CA204969

National Cancer Institute

Grant: R01CA222251

National Cancer Institute

Grant: R01CA227622

National Cancer Institute

Grant: R01CA271369

Rogel Cancer Center, University of Michigan

Grant: R01CA248310

Rogel Cancer Center, University of Michigan

Grant: U01CA216449

NIH

FWCI

3.95

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S2405803322001285?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803322001285?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trecan.2022.05.005

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35750630

Fields of Study

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerMetabolomics and Mass Spectrometry StudiesAntineoplastic AgentsHumansNeoplasmsTumor Microenvironment

MeSH Terms

Antineoplastic AgentsHumansNeoplasmsTumor Microenvironment

Keywords

Radiation therapyTumor microenvironmentContext (archaeology)CancerCancer researchCancer cellMedicineBiologyTumor cellsInternal medicineDNA repairRadioresistanceFatty acid metabolismMetabolic ReprogrammingRedox Metabolism

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer

10.6084/m9.figshare.25101109.v1figshare

Additional file 1 of FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer

10.6084/m9.figshare.25101109figshare